ABSORB II In-Depth: What Does The Data Tell Us? - P. W. Serruys, MD, PhD

↳ This is a section part of Moment: CRT 2015 Technology & Innovation - BRS Show Me the Data

Add this Moment to your Passport

Learn from this moment and keep it forever.

Add To Passport

$33.99

This moment is included in Simple Premium - Get started for free.

FREE with Simple Premium

Start your 30-day free trial

Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

ABSORB II In-Depth: What Does The Data Tell Us? presented by P. W. Serruys, MD, PhD at CRT 2015

Add this Moment to your Passport

Learn from this moment and keep it forever.

Add To Passport

$33.99

This moment is included in Simple Premium - Get started for free.

FREE with Simple Premium

Start your 30-day free trial

Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

Interventional Cardiologists
Interventional Fellows

Session Name: BRS Show Me the Data

Track: Technology & Innovation

Learning Objectives

Update in advances with bioresorbable technologies in interventional procedures

Other Components in this Moment

Should Bioabsorable Scaffolds be Used in Patients Presenting with AMI - Michael Joner, MD

BRS for STEMI Patients - Azeem Latib, MD

ABSORB II In-Depth: What Does The Data Tell Us? - P. W. Serruys, MD, PhD

Update on the EXTEND Trial - A. Abizaid, MD, PhD

DESolve Series of Studies - A. Abizaid, MD, PhD

The REVA Tyrosine-Derived Polycarbonate Bioabsorbable Scaffold: Program Update and Lessons Learned - A. Abizaid, MD, PhD

Update on the BIOSOLVE Clinical Trial Using DREAMS Absorbable Magnesium Scaffold - J. J. Koolen, MD, PhD

Does BRS Technology Reduce Angina? - Gregg W. Stone, MD

Is BRS Ready for Complex Lesions Results from the GHOST Trial? - Corrado Tamburino, PhD

Unmet Need and Real World Experience of BVS in Europe - Stephan Windecker, MD

Showcases from Sao Paulo - Ricardo A. Costa, PhD

BRS Strut Fracture: Incidence, Prevention and Consequences - Stephen G. Ellis, MD

Regulatory Requirements for BRS Technology in the US - Andrew Farb, MD

The BVS ABSORB III and IV Clinical Trial Update - Gregg W. Stone, MD

Absorb All-Comers Randomized Trial Design: Are We Ready? - P. W. Serruys, MD, PhD

Loading Simple Education